Skip to main content

VanEck Global Healthcare Leaders ETF

HLTHVanEckLast updated: Dec 25

What HLTH does

The VanEck Global Healthcare Leaders ETF (ticker: HLTH) invests in a diverse range of leading healthcare companies from around the world. This ETF aims to provide investors with exposure to the global healthcare sector, including pharmaceuticals, biotechnology, and medical devices, without tracking a specific benchmark. With a management fee of 0.45%, HLTH focuses on selecting companies that are leaders in innovation and have strong growth potential, offering a way for investors to benefit from advancements in healthcare and medical technology.

Management Fee

0.45%

Distribution Yield

0.16%

Fund Under Management

$54M

-2.73M

Monthly Liquidity

4.68%

Spread

0.54%

Last Price

...

Product Type

ETF

Monthly fund flows

12-Month Flow

+$0.16M

Trading Activity

Transacted Value

$3M

Volume

204,800

Number of Trades

579

Monthly Liquidity

4.68%

Performance

1 Month

-4.88%

1 Year

9.16%

3 Year

5.72%

5 Year

4.19%

Total Return

Share Price Chart

Related ETFs

Resources

Rask Australia
from

Want Expert ETF Portfolio Guidance?

Get access to Owen Rask's expert ETF portfolios, ongoing research, and 10+ investing courses.

✓ 50+ years experience • ASIC licensed • Cancel anytime

Should you buy VanEck Global Healthcare Leaders ETF right now?

While HLTH looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.

Join the Rask weekly investment newsletter to get the names, right now